← Back to Search

Peer Navigation + Kidney Transplant Fast Track for Improving Access to Kidney Transplants in Minority Populations (AKT-MP Trial)

N/A
Recruiting
Led By Larissa Myaskovsky, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Greater than or equal to 18 years of age
Mentally competent
Must not have
Children less than 18 years of age
Prior kidney transplant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two approaches to help Hispanic/Latino and American Indian patients overcome barriers to completing transplant evaluation and receiving a kidney transplant.

Who is the study for?
This trial is for adults over 18 with kidney disease, specifically Hispanic/Latino and American Indian patients at the University of New Mexico. They must be mentally competent and not currently waitlisted at another center or have had a previous kidney transplant. Pregnant women, children under 18, incarcerated individuals, those with recent non-skin cancer or cognitive impairments are excluded.
What is being tested?
The study compares two methods to help overcome barriers to getting a kidney transplant: a streamlined evaluation process (KTFT) and peer-assisted support (PN). Participants will be randomly assigned to one of these approaches to see which is more effective and cost-efficient in aiding them through the transplant evaluation process.
What are the potential side effects?
Since this trial focuses on evaluating processes rather than medical treatments, traditional side effects associated with medications are not applicable. However, participants may experience stress or emotional impacts related to navigating the transplantation process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am mentally capable of making my own decisions.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I have had a kidney transplant.
Select...
I currently have an infection that affects my whole body.
Select...
I have not had cancer other than skin cancer in the past 2 years.
Select...
I have been diagnosed with cognitive impairment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of KT evaluation completion
Secondary study objectives
KT ambivalence
Patient Reported Quality of Life

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
PN
Group II: Arm 1Experimental Treatment1 Intervention
KTFT

Find a Location

Who is running the clinical trial?

University of PittsburghOTHER
1,789 Previous Clinical Trials
16,359,225 Total Patients Enrolled
University of Massachusetts, AmherstOTHER
81 Previous Clinical Trials
467,752 Total Patients Enrolled
University of New MexicoLead Sponsor
386 Previous Clinical Trials
3,525,681 Total Patients Enrolled

Media Library

Kidney Transplant Fast Track (KTFT) Clinical Trial Eligibility Overview. Trial Name: NCT04615819 — N/A
Kidney Disease Research Study Groups: Arm 1, Arm 2
Kidney Disease Clinical Trial 2023: Kidney Transplant Fast Track (KTFT) Highlights & Side Effects. Trial Name: NCT04615819 — N/A
Kidney Transplant Fast Track (KTFT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04615819 — N/A
~169 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top